Prosecution Insights
Last updated: October 02, 2026

Examiner: HALL, DEANNA K

Tech Center 3700 • Art Units: 3763 3767 3783

This examiner grants 76% of resolved cases

Analysis

Deanna K. Hall has managed a large number of 1170 resolved cases within Art Unit 3763. The examiner demonstrates a high allowance rate of 75.6%, which suggests a favorable environment for patent applicants in Tech Center 3700. This rate indicates that the majority of applications reach allowance under this examiner's review.

The interview lift is recorded at 15.7%. While positive, this lift is modest compared to the baseline allowance rate of 75.6%. The median days to allowance stands at 1167, providing a clear timeline for prosecution expectations when working with this examiner. With this volume of resolved cases, the data set is robust and suggests consistent performance. Practitioners can use the 1167 median days to allowance to manage client expectations regarding the speed of the patent grant process. The 15.7% interview lift remains a useful tool for cases that encounter specific obstacles.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

75.7%
Allow Rate
+5.7% vs TC avg
1,215
Total Applications
+15.7%
Interview Lift
1167
Avg Prosecution Days
Based on 1171 resolved cases, 2023–2026

Rejection Statute Breakdown

1.3%
§101 Eligibility
32.2%
§102 Novelty
49.6%
§103 Obviousness
11.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18007039 BIODEGRADABLE MICRONEEDLE PATCH FOR TRANSDERMAL GENE DELIVERY Non-Final OA THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
17772418 PERIODONTAL MICROPATCH AND USES THEREOF Non-Final OA The Regents of the University of California
18723736 Sealing Film with Perimeter Edge Weakness for Tamper Evident Protection Non-Final OA Solventum Intellectual Properties Company
18781109 ARTICULABLE OTOLOGIC SUCTION TUBE AND SUCTION TUBE SYSTEM Non-Final OA Alcon Inc.
18543581 SELECTIVELY MOVEABLE VALVE ELEMENTS FOR ASPIRATION AND IRRIGATION CIRCUITS Non-Final OA Alcon Inc.
18663396 PREDICTIVE INFUSION DEVICE OPERATIONS AND RELATED METHODS AND SYSTEMS Non-Final OA Medtronic MiniMed, Inc.
18344768 HYDRAULICALLY ACTUATED SUBCUTANEOUS VALVE DEVICE, SYSTEM AND METHOD Final Rejection Medtronic MiniMed, Inc.
18682965 Drug Delivery Device with Cannula Having Bioactive Agent Final Rejection Becton, Dickinson and Company
18203951 Battery-Free Sensing Solution for Drug Delivery Devices Final Rejection Becton, Dickinson and Company
18254677 APPARATUSES AND METHODS FOR PAUSING AN INFUSION PUMP DURING A DISPENSE STROKE TO IMPROVE OCCLUSION SENSING Final Rejection Becton, Dickinson and Company
18154152 Vascular Access Device with Over-the-Catheter Introducer Needle and Near Patient Access Port Final Rejection Becton, Dickinson and Company
18084644 Brush/Foam-Based Applicator for Dispensing Tissue Adhesive Final Rejection Becton, Dickinson and Company
18039455 User Device, System and Method for Determining a Threshold Time for an Injection Device to Transition to an Operational Temperature Final Rejection Sanofi
18662414 Medicament Delivery Device with Use Indicator Non-Final OA Sanofi-Aventis Deutschland GmbH
17841987 METHODS AND COMPOSITIONS FOR INCREASING CIRCULATION DURING TREATMENT WITH ALTERNATING ELECTRIC FIELDS Non-Final OA Novocure GMBH
18344488 PLASMA TREATMENT DEVICE Non-Final OA AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
18626920 DIAGNOSTIC CATHETERS, GUIDE CATHETERS, VISUALIZATION DEVICES AND CHORD MANIPULATION DEVICES, AND RELATED KITS AND METHODS Non-Final OA Ancora Heart, Inc.
18645779 CONTROLLABLE DRUG DELIVERY SYSTEM AND METHOD OF USE Non-Final OA AMGEN INC.
17630207 DRUG DELIVERY DEVICE WITH TEMPERATURE MEASUREMENT AND RELATED METHOD Non-Final OA AMGEN INC.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month